Wednesday, November 24, 2010

Bayer Settles Multivitamin Prostate Cancer Claim Litigation

Bayer has agreed to a $3.3 million settlement with 3 states "over the company's unsupported claim that One A Day Men's Health Formula multivitamins reduce the risk of prostate cancer," according to the Oregon Department of Justice, which filed a complaint along with the attorney generals of California and Illinois.

Bayer will be barred from claiming that its One A Day multivitamins might cure, treat, or prevent any disease, including cancer, unless the company "can back up such claims with competent and reliable scientific evidence," according to the CSPI.
The heart of the current controversy is related to qualified health claims about selenium, an ingredient in the One A Day Men's Health Formula multivitamin.

Read more here.